...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors
【24h】

Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors

机译:组氨酸N(τ) - 环状大键作为一种新的Polo样激酶1个Polo-Box结构域结合抑制剂

获取原文
获取原文并翻译 | 示例

摘要

Transition toward peptide mimetics of reduced size is an important objective of peptide macrocyclization. We have previously shown that PLH?SpT (2a) (where H?indicates the presence of a –(CH2)8Ph group at the N(π) position and pT indicates phosphothreonine) is an extremely high affinity ligand of the polo-like kinase 1 (Plk1) polo-box domain (PBD). Herein we report thatC-terminal macrocyclization of2aemploying N(π),N(τ)-bis-alkylated His residues as ring junctions can be achieved in a very direct fashion. The resulting macrocycles are highly potent in biochemical assays and maintain good target selectivity for the Plk1 PBD versus the PBDs of Plk2 and Plk3. Importantly, as exemplified by5d, our current approach permits deletion of theN-terminal “Pro-Leu” motif to yield tripeptide ligands with decreased molecular weight, which retain high affinity and show improved target selectivity. These findings could fundamentally impact the future development of peptide macrocycles in general and Plk1 PBD-binding peptide mimetics in particular.
机译:朝向肽的转变减小的肽模拟物是肽宏核的重要目标。我们之前已经表明plh?spt(2a)(其中h?表示N(π)位置和pt表示磷酸萘酶的pO(π)的存在 - (ch2)8ph基团)是酚类激酶的极高亲和力配体1(PLK1)Polo-Box域(PBD)。在此,我们将2aemplipling n(π),N(τ)的-bis-烷基化的残留物作为环形交叉点以非常直接的方式实现的。所得宏依克斯在生化测定中具有高效性,并保持PLK1 PBD的良好目标选择性与PLK2和PLK3的PBD。重要的是,如图所示,如图5D所示,我们目前的方法允许删除终端“Pro-Leu”图案,以产生具有降低的分子量的三肽配体,其保留高亲和力并显示出改善的靶选择性。这些发现可以从根本上产生肽宏杂种的未来发展,并且特别是PLK1 PBD结合肽模拟物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号